1. Home
  2. ABUS vs NSP Comparison

ABUS vs NSP Comparison

Compare ABUS & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.37

Market Cap

848.8M

Sector

Health Care

ML Signal

HOLD

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$31.36

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
NSP
Founded
2005
1986
Country
United States
United States
Employees
19
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
848.8M
1.1B
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
ABUS
NSP
Price
$4.37
$31.36
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$5.00
$47.67
AVG Volume (30 Days)
1.6M
684.4K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
6.45%
EPS Growth
55.26
N/A
EPS
0.87
0.88
Revenue
$14,083,000.00
$6,812,000,000.00
Revenue This Year
N/A
$3.45
Revenue Next Year
$239.71
$6.95
P/E Ratio
$4.80
$35.97
Revenue Growth
128.21
3.51
52 Week Low
$3.04
$18.57
52 Week High
$5.10
$67.82

Technical Indicators

Market Signals
Indicator
ABUS
NSP
Relative Strength Index (RSI) 51.67 53.03
Support Level $4.17 $31.00
Resistance Level $4.60 $33.42
Average True Range (ATR) 0.16 2.36
MACD -0.00 -0.21
Stochastic Oscillator 62.50 60.62

Price Performance

Historical Comparison
ABUS
NSP

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: